eTheRNA is an RNA technology company that specializes in the development of innovative RNA therapeutics, leveraging over 30 years of experience in the field. The company offers professional partnerships to pharmaceutical and biotech firms, supporting projects at various stages of development through its proprietary platforms in RNA chemistry, lipid nanoparticle (LNP) formulation, and process technology. eTheRNA's LNP platforms are designed for specific routes of administration, such as intravenous, intra-tumoral, and intramuscular delivery, which enhance targeted biodistribution and improve the safety profile of RNA therapeutics. Their mRNA chemistry platform enables the sequence engineering of mRNA constructs, optimizing them for translation efficiency and stability, while also allowing for immune modulation.

The company has developed proprietary mRNA adjuvants, TriMix and TetraMix, which are designed to enhance the efficacy of T-cell vaccines by activating dendritic cells to induce vaccine-specific T cells. eTheRNA's capabilities extend to customized LNP development, which is crucial for advancing nucleic acid-based products. Their world-class manufacturing facilities in Belgium support the production of LNPs for preclinical projects and scale-up to GMP-ready stages. Through collaborations, such as the recent partnership with Hasselt University, eTheRNA aims to explore new therapeutic avenues, particularly in autoimmune diseases, by combining their expertise in mRNA and LNP technologies with advanced immunological research.

Belgium

Driving discovery and solving challenges for partners across LNP formulation and RNA chemistry | www.etherna.be | www.ethernamanufacturing.com

We are an RNA technology company, with over 30 years’ experience, offering professional partnership to pharma and biotech with an emerging or established interest in RNA therapeutics. Our expert team supports start-up, early stage and late stage projects by using our proprietary platforms across RNA chemistry, LNP formulation and Process Technology, to drive new pipeline development or resolve manufacturing challenges for our partners.

eTheRNA

Company Details